// App-Quantinova.ai

e16514 : Prognostication of outcome in men with bone metastatic castration-resistant-prostate-cancer with early rising PSA after initiation of abiraterone acetate.

Researchers

Presenter

  • Martin Boegemann

Principal Investigators

  • Phillip Grossmann

  • Julie Steinestel

  • Katrin Schlack

  • Laura Maria Krabbe

  • Benedikt Brucher

Medical Centers

  • University of Muenster Medical Center, Munster, Germany

  • Department of Urology, University of Muenster, Munster, Germany

  • University of Muenster Medical Center, Department of Urology, Muenster, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved